TransVar: a multilevel variant annotator for precision genomics

注释 生物 计算生物学 基因组学 基因亚型 遗传学 基因组 基因组DNA 基因
作者
Wanding Zhou,Tenghui Chen,Zechen Chong,Mary A. Rohrdanz,James Melott,Chris Wakefield,Jia Zeng,John N. Weinstein,Funda Meric‐Bernstam,Gordon B. Mills,Ken Chen
出处
期刊:Nature Methods [Springer Nature]
卷期号:12 (11): 1002-1003 被引量:73
标识
DOI:10.1038/nmeth.3622
摘要

One DNA sequence can code for multiple different mRNAs, and therefore many different proteins. Conversely, a variant identified at the protein or transcript level may have non-unique genomic origins. For example, EGFR:p.L747S, which mediates acquired resistance of non-small cell lung cancer to tyrosine kinase inhibitors1, can be translated from multiple genomic variants such as chr7:g.55249076_55249077delinsAG and chr7:g.55242470T>C on different isoforms defined on the human reference assembly GRCh37. One-to-many, many-to-one and many-to-many relationships among sequence variants at the genomic level and those at transcript and protein levels introduce frequent inconsistencies in current practice when vital information about the annotation process (e.g., transcript or isoform IDs) is omitted from variant identifiers. To facilitate standardization and reveal inconsistency in existing variant annotations, we have designed a novel variant annotator, TransVar, to perform three main functions supporting diverse reference genomes and transcript databases (Fig. 1a): (i) “forward annotation”, which annotates all potential effects of a genomic variant on mRNAs and proteins; (ii) “reverse annotation”, which traces an mRNA or protein variant to all potential genomic origins; and (iii) “equivalence annotation”, which, for a given protein variant, searches for alternative protein variants that have identical genomic origin but are represented based on different isoforms. Figure 1 Schematic overview of TransVar and comparison of TransVar with other tools. (a) TransVar performs forward (green arrows) and reverse annotation (pink arrows) and considers all possible mRNA transcripts or protein isoforms available in user-specified reference ... We annotated 964,132 unique single-nucleotide substitutions (SNS), 3,715 multi-nucleotide substitutions (MNS), 11,761 insertions (INS), 24,595 deletions (DEL) and 166 block substitutions (BLS) in the Catalogue of Somatic Mutations in Cancer (COSMIC v67) using TransVar, ANNOVAR2, VEP3, snpEff4, and Oncotator5, and asked whether the resulting protein identifiers (gene name, protein coordinates, and reference amino acid (AA)) match those in COSMIC. We observed comparable consistency in SNS and MNS but variable consistency in INS, DEL and BLS from different annotators (Fig. 1b, Supplementary Table 1 and Supplementary Notes). That finding can largely be attributed to a lack of standardization among variant annotations (codon or AA positions of variants) submitted to COSMIC and among conventions implemented in various annotators. Inconsistency in annotations blurred the lines of evidence for variant frequency estimation and led to inaccurate determination of variant function. TransVar revealed hidden inconsistency in these variant annotations by comprehensively outputting alternative annotations in all available transcripts in standard HGVS nomenclature, and thus resulted in greater consistency in this experiment. TransVar’s novel reverse annotation can be used to ascertain if two protein variants have identical genomic origin, thus reducing inconsistency in annotation data. It can also reveal whether or not a protein variant has non-unique genomic origins and requires caution in genetic and clinical interpretation. We reverse-annotated the protein level variants in COSMIC and found that even under the constraints imposed by the reference base or AA identity, a sizeable fraction (e.g., 11.9% of single-AA substitutions) were associated with multiple genomic variants (Supplementary Table 2), if transcripts were not specified. Among the 537 variants that were cited as clinically actionable at PersonalizedCancerTherapy.org, 78 (14.5%) (e.g., CDKN2A:p.R87P and ERBB2:p.L755_T759del) could be mapped to multiple genomic locations (Supplementary Table 3). The reverse-annotation functionality also enabled systematic genomic characterization of variants directly identified from proteomic or RNA-seq data. For example, we were able to identify in just a few minutes of compute-time the putative genomic origins of 187,464 (97.69%) protein phosphorylation sites (e.g., p.Y308/p.S473 in AKT1 and p.Y1068/p.Y1172 in EGFR) in human proteins6. Our investigation revealed frequent inconsistencies in current databases and tools and highlighted the importance of standardization. With both forward and reverse annotation enabled in TransVar, we can reveal hidden inconsistency and improve the precision of translational and clinical genomics. The source code and detailed instructions of TransVar is available at https://bitbucket.org/wanding/transvar and a web interface is at http://www.transvar.net.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
赘婿应助单纯的巧荷采纳,获得10
刚刚
刚刚
英俊的铭应助景笑天采纳,获得10
刚刚
1秒前
画个圈圈恋上荣完成签到,获得积分10
1秒前
2秒前
2秒前
Ava应助Y.B.Cao采纳,获得10
2秒前
科研通AI2S应助明理思真采纳,获得10
2秒前
sjc发布了新的文献求助20
3秒前
Potato发布了新的文献求助10
5秒前
姆问题发布了新的文献求助10
5秒前
5秒前
6秒前
6秒前
Epiphany发布了新的文献求助10
6秒前
Creamai完成签到,获得积分10
6秒前
IC完成签到,获得积分20
6秒前
勤劳亦瑶应助春和景明采纳,获得10
8秒前
8秒前
Bell发布了新的文献求助10
9秒前
Ava应助LAN0528采纳,获得10
9秒前
在下废物发布了新的文献求助10
9秒前
互助遵法尚德应助一休采纳,获得10
10秒前
安静的凡松完成签到,获得积分10
10秒前
Tina完成签到 ,获得积分10
10秒前
程大海发布了新的文献求助10
11秒前
幸福大白发布了新的文献求助10
11秒前
科研鲁宾孙完成签到,获得积分10
13秒前
Y.B.Cao发布了新的文献求助10
14秒前
笨笨的寒烟应助Weirdo采纳,获得10
14秒前
IC发布了新的文献求助10
14秒前
15秒前
15秒前
16秒前
bkagyin应助姆问题采纳,获得10
16秒前
18秒前
18秒前
ding应助戴先森采纳,获得10
19秒前
19秒前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
юрские динозавры восточного забайкалья 800
Diagnostic immunohistochemistry : theranostic and genomic applications 6th Edition 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi 400
Classics in Total Synthesis IV 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3149808
求助须知:如何正确求助?哪些是违规求助? 2800840
关于积分的说明 7842296
捐赠科研通 2458378
什么是DOI,文献DOI怎么找? 1308434
科研通“疑难数据库(出版商)”最低求助积分说明 628510
版权声明 601721